selected scholarly activity
-
chapters
- Addison Disease. 65-76. 2020
- Oncodynamic Effect of Cancer on Depression. 105-127. 2016
- Psychosis associated with leukodystrophies. 241-256. 2010
- Catatonia. Current Clinical Neurology. 81-92. 2006
- Acute Drug‐Induced Dystonia. 72-102. 2005
-
conferences
- Prevalence of unrecognised neurological diagnoses in patients referred with conversion disorder. Journal of Neurology. S142-S142. 2012
- Metabolic Abnormalities in the Caudate in Patients with Mitochondrial Disorders Measured Using Proton Magnetic Resonance Spectroscopy. Annals of Neurology. S81-S81. 2012
- Antidepressant medication induces persistent downregulation of brainstem serotonergic neurons: Potential relevance to withdrawal syndrome. International Journal of Neuropsychopharmacology. S212-S212. 2006
- Haloperidol-induced downregulation of dopamine neurons in the substantia nigra is attenuated by caffeine and nicotine. International Journal of Neuropsychopharmacology. S220-S220. 2006
- Rapid downregulation of midbrain dopamine neurons following administration of haloperidol: Potential relevance to drug-induced side effects. International Journal of Neuropsychopharmacology. S126-S126. 2006
- Treatment of conversion disorder. PSYCHOGENIC MOVEMENT DISORDERS: NEUROLOGY AND NEUROPSYCHIATRY. 289-+. 2006
- Rapid induction of proapoptotic proteins in nigral dopamine neurons by antipsychotic medication. Annals of Neurology. S42-S42. 2003
- Evidence that antipsychotic drugs and 3-nitroproprionic acid independently induce cell death in midbrain dopamine neurons by activation of the apoptosis cascade. Annals of Neurology. S85-S86. 2002
- Postconcussion syndrome is accompanied by prolonged latencies of visual evoked responses. Annals of Neurology. S28-S28. 2002
- Compromised mitochondrial function exacerbates the Parkinson's disease-like changes induced by antipsychotic drugs. Annals of Neurology. 464-464. 2000
- Neurological disorders in catatonic patients admitted to psychiatry. Annals of Neurology. 465-465. 2000
- Can neuroleptic drugs cause Parkinson's disease?. Annals of Neurology. 478-478. 1999
- POSITRON EMISSION TOMOGRAPHY SCAN STUDIES IN A PRIMATE MODEL OF STRIATAL DEGENERATION - IMPLICATIONS FOR THE MITOCHONDRIAL HYPOTHESIS OF HUNTINGTONS-DISEASE. Annals of Neurology. 316-316. 1994
-
journal articles
- Delphi consensus study to develop guidelines for the management of adults with borderline personality disorder in the emergency department: a protocol. BMJ Open. 13:e075119-e075119. 2023
- Does early antipsychotic response predict long‐term treatment outcome?. Human Psychopharmacology. 32. 2017
- Mental illness in patients with inherited mitochondrial disorders. Schizophrenia Research. 187:33-37. 2017
- The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects. Journal of Clinical Psychopharmacology. 37:8-12. 2017
- The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine. Psychiatry Research. 241:72-77. 2016
- Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. WORLD JOURNAL OF PSYCHIATRY. 6:391-391. 2016
- Cushing Disease Presenting as Primary Psychiatric Illness. Journal of Psychiatric Practice. 21:449-457. 2015
- Mitochondrial Involvement in Psychiatric Illness in Adults. Current Psychiatry Research and Reviews. 10:192-199. 2014
- Metabolite measurements in the caudate nucleus, anterior cingulate cortex and hippocampus among patients with mitochondrial disorders: a case-control study using proton magnetic resonance spectroscopy. CMAJ open. 1:E48-E55. 2013
- Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders. Translational Psychiatry. 2:e187-e187. 2012
- The Psychiatric Presentation of Mitochondrial Disorders in Adults. Journal of Neuropsychiatry and Clinical Neurosciences. 24:394-409. 2012
- The mitochondrial genome and psychiatric illness. American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics. 159B:749-759. 2012
- Psychotropic medications and mitochondrial toxicity. Nature Reviews Neuroscience. 13:650-650. 2012
- The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus. Synapse. 66:465-470. 2012
- The Psychiatric Manifestations of Mitochondrial Disorders. Journal of Clinical Psychiatry. 73:506-512. 2012
- Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse. 65:1166-1172. 2011
- An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method. Journal of Clinical Psychiatry. 72:1222-1228. 2011
- The psychiatric manifestations of mitochondrial cytopathies: A clinical and MR spectroscopy investigation. Mitochondrion. 11:639-640. 2011
- Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons. Brain Research. 1394:24-32. 2011
- Treatment of Conversion Disorder in the 21st Century: Have We Moved Beyond the Couch?. Current Treatment Options in Neurology. 13:255-266. 2011
- Neuroleptic malignant syndrome: a neuroimmunologic hypothesis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:E834-E838. 2010
- Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Journal of ECT. 26:246-247. 2010
- Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity. Neuroscience. 171:407-420. 2010
- Catatonia and Its Treatment. Schizophrenia Bulletin. 36:239-242. 2010
- Treating Psychiatric Illness in Patients With Mitochondrial Disorders. Journal of the Academy of Consultation-Liaison Psychiatry. 51:179-179. 2010
- Neuroleptic Malignant Syndrome and the Acute Phase Response. Journal of Clinical Psychopharmacology. 28:459-461. 2008
- The Neuropsychiatric Profile of Addison's Disease: Revisiting a Forgotten Phenomenon. Journal of Neuropsychiatry and Clinical Neurosciences. 18:450-459. 2006
- The Neuropsychiatric Profile of Addison’s Disease: Revisiting a Forgotten Phenomenon. Journal of Neuropsychiatry and Clinical Neurosciences. 18:450-459. 2006
- Recognizing neuroleptic malignant syndrome. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:1645-1645. 2004
- Serotonin syndrome: not a benign toxidrome.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 169:543. 2003
- Identification and Treatment of Neuroleptic Malignant Syndrome. Child and Adolescent Psychopharmacology News. 6:1-6. 2001
- Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone. Neurology. 55:1069-1069. 2000
- Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.. Neurology. 54:1543-1544. 2000
- Magnetic Resonance Imaging Abnormalities and Psychiatric Illness. American Journal of Psychiatry. 157:306-307. 2000
- Foundations for the classification of catatonias. Movement Disorders. 15:180-180. 2000
- Reply. Movement Disorders. 15:180-181. 2000
- The Neuropsychiatry of Adult-Onset Adrenoleukodystrophy. Journal of Neuropsychiatry and Clinical Neurosciences. 11:315-327. 1999
- Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms. Journal of Clinical Psychiatry. 60:460-468. 1999
- Serotonin Syndrome as a Result of Clomipramine Monotherapy. Journal of Clinical Psychopharmacology. 19:285-287. 1999
- Catatonia: Re-awakening to a forgotten disorder. Movement Disorders. 14:395-397. 1999
- Catatonia Following Gabapentin Withdrawal. Journal of Clinical Psychopharmacology. 19:188-189. 1999
- Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone. Neurology. 52:782-782. 1999
- Persistent loss of tyrosine hydroxylase immunoreactivity in the substantia nigra after neuroleptic withdrawal. Journal of Neurology, Neurosurgery and Psychiatry. 64:799-801. 1998
- Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat. Neuroscience. 84:201-211. 1998
- Neuropsychiatric Aspects of the Adult Variant of Tay-Sachs Disease. Journal of Neuropsychiatry and Clinical Neurosciences. 10:10-19. 1998
- Protracted akathisia after risperidone withdrawal. American Journal of Psychiatry. 154:437b-438. 1997
- Catatonia After Benzodiazepine Withdrawal. Journal of Clinical Psychopharmacology. 16:315-319. 1996
- Circadian pattern of acute, neuroleptic-induced dystonic reactions. American Journal of Psychiatry. 153:708-710. 1996
- Complicating Factors in the Analysis of Acute Drug-Induced Akathisia. JAMA psychiatry. 52:878-878. 1995
- Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.. Journal of Clinical Psychiatry. 56:347-353. 1995
- Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.. Journal of Clinical Psychiatry. 55:20-23. 1994
- Do benzodiazepines modify the incidence of neuroleptic-induced dystonia?. American Journal of Psychiatry. 150:528-529. 1993
- AIDS-related psychosis with catatonia responding to low-dose lorazepam.. Journal of Clinical Psychiatry. 53:414-415. 1992
- The Treatment of Catatonia: Benzodiazepines or ECT?. American Journal of Psychiatry. 149:1279-1279. 1992
- The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?. The British journal of psychiatry. Supplement. 159:709-712. 1991
- Iron in neuroleptic malignant syndrome. The Lancet. 338:820-821. 1991
- Serum iron and neuroleptic malignant syndrome. The Lancet. 338:149-151. 1991
- Lorazepam and catatonia.. Journal of Clinical Psychiatry. 52:186-188. 1991
- Bromocriptine and neuroleptic malignant syndrome.. Journal of Clinical Psychiatry. 52:41-42. 1991
- Dr. Rosebush and Dr. Mazurek Reply. American Journal of Psychiatry. 148:148-a-149. 1991
- Tardive Dyskinesia and the Law. Canadian Journal of Psychiatry. 35:573-574. 1990
- Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.. Journal of Clinical Psychiatry. 51:357-362. 1990
- Erratum: Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients (J. Clin. Psychiatry, August 1989 issue, pp 295-298). Journal of Clinical Psychiatry. 50:472. 1989
- Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients.. Journal of Clinical Psychiatry. 50:295-298. 1989
- A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry. 146:717-725. 1989
- Double-blind, placebo-controlled studies of bulimic patients.. American Journal of Psychiatry. 143:1197-1198. 1986
-
other
- Psychopharmacology for the clinician psychoparmacologie pratique. Journal of Psychiatry & Neuroscience. 240. 2003